Shionogi & Co Ltd

Common Name

Shionogi & Co

Country

Japan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

4,955

Ticker

4507

Exchange

TOKYO STOCK EXCHANGE

Website

www.shionogi.com

Description

Shionogi & Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and distribution of pharmaceutical products. Established in Japan in 1878, Shionogi focuses primaril... Show more

Income Statement Balance Sheet Group Entities

Shionogi & Co's Financial Statements Preview

Below are the financial statements of Shionogi & Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of JPY	2024 as of 2024-03-31	2023 as of 2023-03-31
Assets	—	—
Non-current assets	—	—
Property, plant and equipment	114.59^a	112.09^a
Goodwill	15.29^a	9.82^a
Intangible assets	117.62^a	96.31^a
Right-of-use assets	9.44^a	6.48^a
Investment property	27.77^a	26.38^a
Other financial assets	292.32^a	247.71^a
Deferred tax assets	13.53^a	22.1^a
Other non-current assets	42.16^a	6.72^a
Total non-current assets	632.71^a	527.61^a
Current assets	—	—
Inventories	64.92^a	57.92^a
Trade receivables	122.83^a	109.77^a
Other financial assets	215.76^a	254.13^a
Other current assets	22.61^a	53.14^a
Cash and cash equivalents	358.09^a	309.22^a
Total current assets	784.21^a	784.19^a
Total assets	1,416.92^a	1,311.8^a
Equity and liabilities	—	—
Equity	—	—
Share capital	21.28^a	21.28^a
Capital surplus	14.24^a	15.2^a
Treasury shares	-137.89^a	-63.07^a
Retained earnings	1,065.91^a	940.61^a
Other components of equity	271.78^a	186.03^a
Equity attributable to owners of parent	1,235.33^a	1,100.05^a
Non-controlling interests	17.24^a	21.83^a
Total equity	1,252.56^a	1,121.88^a
Liabilities	—	—
Non-current liabilities	—	—
Lease liabilities	8.75^a	6.4^a
Other financial liabilities	7.65^a	4.84^a
Retirement benefit liability	7.99^a	12.87^a
Deferred tax liabilities	4.36^a	5.92^a
Other non-current liabilities	1.69^a	1.34^a
Total non-current liabilities	30.45^a	31.37^a
Current liabilities	—	—
Lease liabilities	2.87^a	3.01^a
Trade payables	14.81^a	14.01^a
Other financial liabilities	31.12^a	29.72^a
Income taxes payable	20.84^a	42.22^a
Other current liabilities	64.27^a	69.6^a
Total current liabilities	133.91^a	158.55^a
Total liabilities	164.36^a	189.92^a
Total equity and liabilities	1,416.92^a	1,311.8^a

Download Data

Verified Sources Behind Shionogi & Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shionogi & Co’s data sources below and access millions more through our Disclosure Search.

a. Shionogi & Co's Integrated Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Shionogi & Co Ltd

Shionogi & Co's Financial Statements Preview

Verified Sources Behind Shionogi & Co’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Eisai Co Ltd

Cosmos Pharmaceutical Corp

Kyowa Kirin Co Ltd

Chugai Pharmaceutical Co Ltd

Ono Pharmaceutical Co Ltd

Sugi Holdings Co Ltd